PAM
CSTL icon

Panagora Asset Management’s Castle Biosciences CSTL Stock Holding History

Panagora Asset Management’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.18M Buy
301,040
+78,687
+35% +$1.75M 0.02% 395
2026
Q1 		$5.46M Buy
222,353
+176,358
+383% +$5.78M 0.02% 395
2025
Q4 		$1.79M Buy
45,995
+24,597
+115% +$793K 0.01% 594
2025
Q3 		$487K Buy
+21,398
New +$435K ﹤0.01% 808
2021
Q3 		– Sell
-28
Closed -$2K – 1869
2021
Q2 		$2K Buy
+28
New +$1.85K ﹤0.01% 2624
2021
Q1 		– Sell
-16,119
Closed -$1.08M – 2835
2020
Q4 		$1.08M Buy
16,119
+368
+2% +$19.9K 0.01% 940
2020
Q3 		$810K Sell
15,751
-6
-0% -$267 0.01% 977
2020
Q2 		$594K Buy
15,757
+2,392
+18% +$81.7K ﹤0.01% 1139
2020
Q1 		$398K Buy
13,365
+13,166
+6,616% +$397K ﹤0.01% 1213
2019
Q4 		$7K Buy
+199
New +$4.87K ﹤0.01% 2186

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Panagora Asset Management's CSTL Position: Q2 2026 in Review

Panagora Asset Management increased its Castle Biosciences (CSTL) stake by 35% in Q2 2026, buying an estimated $1.75M and bringing the position to 301,040 shares worth $7.18M. The position accounts for 0.02% of the portfolio, ranked #395.

Panagora Asset Management first reported a position in CSTL in Q4 2019 and has held it in 10 quarters since. 176 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Panagora Asset Management held 301,040 shares of Castle Biosciences worth $7.18M as of Q2 2026.
  • Panagora Asset Management bought 78,687 Castle Biosciences shares in Q2 2026, an estimated $1.75M.
  • Castle Biosciences made up 0.02% of Panagora Asset Management's portfolio in Q2 2026, its #395 holding.
  • Panagora Asset Management first reported a position in Castle Biosciences in Q4 2019 and has held it in 10 quarters since.
  • 176 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.